Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 238 Records) |
| Query Trace: Death and KRAS[original query] |
|---|
| Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands. JTO clinical and research reports 2023 9 4 (9): 100543. Anneloes L Noordhof, Esther M Swart, Ronald A M Damhuis, Lizza E L Hendriks, Peter W A Kunst, Mieke J Aarts, Wouter H van Geff |
| Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations. Biomedicines 2023 9 11 (9): . Anthony Tarabay, Alice Boileve, Cristina Smolenschi, Leony Antoun, Marine Valery, Alina Fuerea, Audrey Perret, Pascal Burtin, Simona Cosconea, Hichem Belkhodja, David Malka, Valérie Boige, Antoine Hollebecque, Michel Ducre |
| The inherited KRAS-variant as a biomarker of Cetuximab Response in NSCLC. Cancer research communications 2023 9 . Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A Masters, George R Blumenschein, Joe Y Chang, Bo Lu, Adam P Dicker, Jeffrey A Bogart, Yolanda I Garces, Samir Narayan, Clifford G Robinson, Vivek S Kavadi, Joel S Greenberger, Christopher D Koprowski, James W Welsh, Elizabeth Gore, Robert M MacRae, Rebecca Paulus, Jeffrey Bradl |
| Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer. Internal medicine journal 2023 9 . Udit Nindra, Abhijit Pal, Victoria Bray, Po Y Yip, Annette Tognela, Tara L Roberts, Therese M Becker, Jonathon Williamson, Mahtab Farzin, Jing J Li, Vivienne Lea, Abeer Hagelamin, Weng Ng, Bin Wang, C Soon Lee, Wei Ch |
| PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
| Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study. Cancer medicine 2023 11 . Jingyi Guo, Qun Zhou, Mingzhen Zhou, Hengheng Dai, Lin Li, Yudong Qiu, Liang Mao, Baorui Liu, Jie Sh |
| Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C. The New England journal of medicine 2023 10 . Marwan G Fakih, Lisa Salvatore, Taito Esaki, Dominik P Modest, David P Lopez-Bravo, Julien Taieb, Michalis V Karamouzis, Erika Ruiz-Garcia, Tae-Won Kim, Yasutoshi Kuboki, Fausto Meriggi, David Cunningham, Kun-Huei Yeh, Emily Chan, Joseph Chao, Yaneth Saportas, Qui Tran, Chiara Cremolini, Filippo Pietranton |
| Molecular genetic analysis of colorectal carcinoma with an aggressive extraintestinal immunohistochemical phenotype. Scientific reports 2024 9 14 (1): 22241. Jan Hrudka, Markéta Kalinová, Hana Fišerová, Karolína Jelínková, Andrej Nikov, Petr Waldauf, Radoslav Mat |
| Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2. Oncology research 2024 9 32 (9): 1429-1438. Yuzhi Liu, Evelyne Bischof, Zhiqin Chen, Jiahuan Zhou, Bei Zhang, Ding Zhang, Yong Gao, Ming Qu |
| Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations. Hematology (Amsterdam, Netherlands) 2024 8 29 (1): 2392469. Yu Liu, Huanchen Cheng, Mei Cheng, Meng Sun, Jun Ma, Tiejun Go |
| Pulmonary adenocarcinoma with enteric differentiation (PAED) without TTF-1 expression is a very rare subtype with limited treatment options and poor prognosis. Oncology 2024 8 . Franziska Maria Kraus, Alexander Traut, Georg Nilius, Jan Volmerig, Andreas Koziorowski, Imke Stöver, Florian Grabellus, Michael Stahl, Daniel C Christo |
| Clinical and molecular features of early onset pancreatic adenocarcinoma. International journal of cancer 2024 8 . Maxime Rémond, Cristina Smolenschi, Anthony Tarabay, Maximiliano Gelli, Elena Fernandez-de-Sevilla, Ali Mouawia, Simona Cosconea, Lambros Tselikas, Remy Barbe, Alina Fuerea, Mohamed A Bani, Marc Deloger, Benjamin Besse, Thomas Pudlarz, Marine Valéry, Valérie Boige, Antoine Hollebecque, Michel Ducreux, Alice Boilè |
| RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer. Clinical lung cancer 2024 8 . Amanda Reyes, Michelle Afkhami, Erminia Massarelli, Jeremy Fricke, Isa Mambetsariev, Xiaochen Li, Giovanny Velasquez, Ravi Salg |
| Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis. Frontiers in oncology 2024 6 14 1396285. Ella A Eklund, Ali Mourad, Clotilde Wiel, Sama I Sayin, Henrik Fagman, Andreas Hallqvist, Volkan I Say |
| Molecular characterization of V(D)J rearrangements in immature acute leukemias. Leukemia research 2024 6 107521. Danielle Tavares Vianna, Barbara da Costa Reis Monte-Mór, Elda Pereira Noronha, Luciana Mayumi Gutiyama, Elaine Sobral da Costa, Maria S Pombo-de-Oliveira, Ilana Zalcbe |
| KRAS Allelic Variants in Biliary Tract Cancers. JAMA network open 2024 5 7 (5): e249840. Gordon Taylor Moffat, Zishuo Ian Hu, Funda Meric-Bernstam, Elisabeth Kathleen Kong, Dean Pavlick, Jeffrey S Ross, Karthikeyan Murugesan, Lawrence Kwong, Anaemy Danner De Armas, Anil Korkut, Milind Javle, Jennifer J Kn |
| Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer. Med (New York, N.Y.) 2024 5 . Jie Zhao, Lu Wang, Anda Zhou, Shidi Wen, Wenfeng Fang, Li Zhang, Jianchun Duan, Hua Bai, Jia Zhong, Rui Wan, Boyang Sun, Wei Zhuang, Yiwen Lin, Danming He, Lina Cui, Zhijie Wang, Jie Wa |
| Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR: a multicenter real-world analysis. Translational lung cancer research 2024 5 13 (4): 861-874. Tian Tian, Yanying Li, Juan Li, Hongyu Xu, Hua Fan, Jiang Zhu, Yongsheng Wang, Feng Peng, Youling Gong, Yijia Du, Xiaoyan Yan, Xiulan He, Ayse Ece Cali Daylan, Andreas Pircher, Shane S Neibart, Yusuke Okuma, Min Hee Hong, Meijuan Huang, You |
| Clinical and molecular heterogeneity associated with tumor sidedness in colorectal liver metastasis: a multicenter propensity cohort study. Hepatobiliary surgery and nutrition 2024 4 13 (2): 214-228. Yibin Wu, Jiamin Zhou, Huipeng Wang, Guojiu Fang, Weiping Zhu, Sanjun Cai, Lu Wa |
| Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes. International journal of cancer 2024 12 . Pooja Mittal, Francesca Battaglin, Yasmine Baca, Joanne Xiu, Alex Farrell, Shivani Soni, Jae Ho Lo, Lesly Torres-Gonzalez, Sandra Algaze, Priya Jayachandran, Karam Ashouri, Alexandra Wong, Wu Zhang, Jian Yu, Lin Zhang, Benjamin A Weinberg, Emil Lou, Anthony F Shields, Richard M Goldberg, John L Marshall, Sanjay Goel, Indrakant K Singh, Heinz-Josef Le |
| Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report. JTO clinical and research reports 2024 12 5 (12): 100745. Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken, Ed Schuuring, Stefan M Wille |
| Clinical and genetic drivers of oligo-metastatic disease in colon cancer. Neoplasia (New York, N.Y.) 2024 12 60 101111. Alessandro Ottaiano, Mariachiara Santorsola, Roberto Sirica, Annabella Di Mauro, Antonella Di Carlo, Monica Ianniello, Francesco Sabbatino, Rosa Castiello, Francesca Del Peschio, Marco Cascella, Francesco Perri, Maurizio Capuozzo, Nicola Martucci, Edoardo Mercadante, Valentina Borzillo, Rossella Di Franco, Francesco Izzo, Vincenza Granata, Carmine Picone, Antonella Petrillo, Massimiliano Berretta, Salvatore Stilo, Luca Tarotto, Anna Chiara Carratù, Gerardo Ferrara, Madhura Tathode, Alessia Maria Cossu, Marco Bocchetti, Michele Caraglia, Guglielmo Nasti, Giovanni Savare |
| STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108058. Andrea De Giglio, Dario De Biase, Valentina Favorito, Thais Maloberti, Alessandro Di Federico, Federico Zacchini, Giulia Venturi, Claudia Parisi, Filippo Gustavo Dall'Olio, Ilaria Ricciotti, Ambrogio Gagliano, Barbara Melotti, Francesca Sperandi, Annalisa Altimari, Elisa Gruppioni, Giovanni Tallini, Francesco Gelsomino, Lorenzo Montanaro, Andrea Ardizzo |
| [A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 12 46 (11): 1038-1048. J Du, X Qiu, J Y Ni, Q L Wang, F Tong, H Z Sha, Y H Zhu, L Qi, W Cai, C Gao, X W Wei, M B Chen, Z Y Qian, M H Cai, M Tao, C L Wang, G C Zheng, H Jiang, A W Dai, J Wu, M H Zhao, X Q Li, B Lu, C B Wang, B R L |
| Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay. BMC cancer 2024 12 24 (1): 1547. Mariana Bisarro Dos Reis, Wellington Dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarã |
| A Rare Case of Primary Hepatic Undifferentiated Pleomorphic Sarcoma: Exploring Cancer-related Gene Mutations. Internal medicine (Tokyo, Japan) 2024 11 . Hiroyuki Suzuki, Michitaka Fukuda, Tomotake Shirono, Reiichiro Kondo, Toshimitsu Tanaka, Takashi Niizeki, Jun Akiba, Hironori Koga, Takumi Kawaguc |
| A Literature Review and Pooled Case Analysis of Cardiofaciocutaneous Syndrome to Estimate Cancer Risk. medRxiv : the preprint server for health sciences 2024 10 . Jazmyn Bess, Toniya Brown, Sonia Bhala, Anaqa Faizer, Muzzammil Ahmadzada, Alicia A Livinski, Alex Pemov, Jung Kim, Philip S Rosenberg, Gina M Ney, Douglas R Stewa |
| Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer. Journal for immunotherapy of cancer 2024 10 12 (10): . Nicolas Zhou, Cheuk H Leung, William N William, Annikka Weissferdt, Apar Pataer, Myrna C B Godoy, Brett W Carter, Frank V Fossella, Anne S Tsao, George R Blumenschein, Xiuning Le, Jianjun Zhang, Ferdinandos Skoulidis, Jonathan M Kurie, Mehmet Altan, Charles Lu, Bonnie S Glisson, Lauren A Byers, Yasir Y Elamin, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Jack A Roth, Hai T Tran, Jia Wu, Luisa M Solis Soto, Humam Kadara, Stephen G Swisher, Ara A Vaporciyan, Don L Gibbons, Heather Y Lin, J Jack Lee, John V Heymach, Marcelo V Negrao, Boris Sepesi, Tina Casco |
| Afatinib plus bevacizumab combination after osimertinib resistance in advanced EGFR-mutant non-small cell lung cancer: Phase II ABCD-study. Lung cancer (Amsterdam, Netherlands) 2024 10 197 107988. Akito Hata, Nobuyuki Katakami, Naoto Takase, Kayoko Kibata, Yuta Yamanaka, Motohiro Tamiya, Masahide Mori, Takashi Kijima, Satoshi Morita, Kazuko Sakai, Kazuto Nish |
| Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma". Thoracic cancer 2024 1 . Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, Tetsuya Isaka, Kanako Shinada, Emi Yoshioka, Atsuya Narita, Kengo Katakura, Tetsuro Kondo, Terufumi Kato, Takuya Nagashima, Haruhiro Saito, Hiroyuki I |
- Page last reviewed:Feb 1, 2024
- Content source: